These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 35856655)
1. Invasive Aspergillus infection of middle ear in a patient treated with secukinumab, methotrexate, and corticosteroids for psoriasis and psoriatic arthritis. Rob F; Školoudík L; Chrobok V; Dědková J; Kašparová P; Podrazilová L J Dermatolog Treat; 2022 Nov; 33(7):3063-3065. PubMed ID: 35856655 [TBL] [Abstract][Full Text] [Related]
2. Psoriasis vulgaris patient with psoriatic arthritis managed with interleukin-17A inhibitor: Balancing benefits and adverse effects. Utama WS; Lestari W; Hajar S; Sylvawani M; Ismida FD; Akele RY Narra J; 2024 Apr; 4(1):e207. PubMed ID: 38798877 [TBL] [Abstract][Full Text] [Related]
3. Successful secukinumab treatment of erythrodermic psoriasis and psoriatic arthritis concomitant with severe noninfectious uveitis: a case report. Lu J; Tang S; Yu N; Yi X; Li Y J Int Med Res; 2020 Nov; 48(11):300060520969494. PubMed ID: 33161790 [TBL] [Abstract][Full Text] [Related]
4. Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis. Elewski BE; Baddley JW; Deodhar AA; Magrey M; Rich PA; Soriano ER; Soung J; Bao W; Keininger D; Marfo K; Patekar M; Sharma A; Shete A; Lebwohl MG JAMA Dermatol; 2021 Jan; 157(1):43-51. PubMed ID: 33001147 [TBL] [Abstract][Full Text] [Related]
5. Secukinumab: A Review in Psoriatic Arthritis. Shirley M; Scott LJ Drugs; 2016 Jul; 76(11):1135-45. PubMed ID: 27299434 [TBL] [Abstract][Full Text] [Related]
6. Novel combination biologic therapy for recalcitrant psoriasis and psoriatic arthritis in a medically complex patient. Hanna S; Youssef P; Lowe P Australas J Dermatol; 2022 Feb; 63(1):e63-e66. PubMed ID: 34813085 [TBL] [Abstract][Full Text] [Related]
7. Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study. Ortolan A; Lorenzin M; Leo G; Pampaloni F; Messina F; Doria A; Piaserico S; Ramonda R Dermatology; 2022; 238(5):897-903. PubMed ID: 35263743 [TBL] [Abstract][Full Text] [Related]
8. Aggravation of discoid lupus erythematosus in a patient with psoriasis and psoriatic arthritis during treatment of secukinumab: A case report and review of literature. Hsieh CY; Tsai TF Lupus; 2022 Jun; 31(7):891-894. PubMed ID: 35438595 [TBL] [Abstract][Full Text] [Related]
10. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362 [TBL] [Abstract][Full Text] [Related]
11. Psoriasis and psoriatic arthritis in a patient with HIV: response to mycophenolate mofetil treatment. Forman SB; Higginson R; Garrett AB J Drugs Dermatol; 2008 Oct; 7(10):972-3. PubMed ID: 19112763 [TBL] [Abstract][Full Text] [Related]
12. Secukinumab retreatment associated psoriasis flare with pustules. El-Komy M; Amer M; Mostafa A; ElKalioby M J Dermatolog Treat; 2022 Mar; 33(2):1107-1110. PubMed ID: 32538223 [TBL] [Abstract][Full Text] [Related]
13. Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis. Reich K; Baraliakos X; Coates LC; Elewski B; Bao W; Kasparek T; Gaillez C; Pournara E; Aassi M; Perella C; Gottlieb AB Br J Dermatol; 2022 Sep; 187(3):438-441. PubMed ID: 35257363 [TBL] [Abstract][Full Text] [Related]
14. Secukinumab in the Treatment of Psoriasis and Psoriatic Arthritis: A Review of the Literature. Abrouk M; Gandy J; Nakamura M; Lee K; Brodsky M; Singh R; Zhu H; Farahnik B; Bhutani T; Koo J Skin Therapy Lett; 2017 Jul; 22(4):1-6. PubMed ID: 28732152 [TBL] [Abstract][Full Text] [Related]
15. Infliximab in psoriasis and psoriatic arthritis. Papoutsaki M; Osório F; Morais P; Torres T; Magina S; Chimenti S; Costanzo A BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278 [TBL] [Abstract][Full Text] [Related]
16. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study. Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801 [TBL] [Abstract][Full Text] [Related]
18. Possible autoimmune hemolytic anemia induced by secukinumab: a case report. Rahman PA; Kalim H; Prawitasari S; Raharjo FM Pan Afr Med J; 2022; 41():41. PubMed ID: 35317476 [TBL] [Abstract][Full Text] [Related]
19. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368 [TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Methotrexate for Chinese Adults With Psoriasis With and Without Psoriatic Arthritis. Yan K; Zhang Y; Han L; Huang Q; Zhang Z; Fang X; Zheng Z; Yawalkar N; Chang Y; Zhang Q; Jin L; Qian D; Li X; Wu M; Xu Q; Zhang X; Xu J JAMA Dermatol; 2019 Mar; 155(3):327-334. PubMed ID: 30698628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]